Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Sets New 12-Month Low at $51.60

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTFGet Free Report) shares hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as $51.60 and last traded at $51.60, with a volume of 0 shares trading hands. The stock had previously closed at $51.60.

Recordati Industria Chimica e Farmaceutica Price Performance

The stock has a market cap of $10.65 billion, a P/E ratio of 26.74 and a beta of 0.29. The company has a 50 day simple moving average of $51.60 and a 200 day simple moving average of $48.35. The company has a current ratio of 1.28, a quick ratio of 0.86 and a debt-to-equity ratio of 0.80.

About Recordati Industria Chimica e Farmaceutica

(Get Free Report)

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.

Read More

Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.